Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Clinical trial NCT02057029 · COMPLETED

Trial details

NCT number: NCT02057029
Sponsor: Yale University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Early Stage Estrogen Receptor (ER) Positive Breast Cancer

Start date: 2014-01-01
Primary completion: 2015-06-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.